APA (7th ed.) Citation

Gocke, C. D., Kopreski, M. S., Benko, F. A., Sternasc, L., & Kwak, L. W. (2000). Serum BCL2/IGH DNA in Follicular Lymphoma Patients: A Minimal Residual Disease Marker. Leukemia & lymphoma, 39(1-2), 165-172. https://doi.org/10.3109/10428190009053551

Chicago Style (17th ed.) Citation

Gocke, Christopher D., Michael S. Kopreski, Floyd A. Benko, Lars Sternasc, and Larry W. Kwak. "Serum BCL2/IGH DNA in Follicular Lymphoma Patients: A Minimal Residual Disease Marker." Leukemia & Lymphoma 39, no. 1-2 (2000): 165-172. https://doi.org/10.3109/10428190009053551.

MLA (9th ed.) Citation

Gocke, Christopher D., et al. "Serum BCL2/IGH DNA in Follicular Lymphoma Patients: A Minimal Residual Disease Marker." Leukemia & Lymphoma, vol. 39, no. 1-2, 2000, pp. 165-172, https://doi.org/10.3109/10428190009053551.